Newtyn Management’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,982
Closed -$231K 89
2022
Q2
$231K Buy
+18,982
New +$231K 0.04% 73